Marshall Wace »

An2 Therapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of An2 Therapeutics (ANTX) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in An2 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including An2 Therapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in An2 Therapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2024-03-31 $268k 83k 3.25
2023-12-31 $6.9M 337k 20.49
2023-09-30 $12M 717k 16.08

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc-a Common Stock (GOOGL)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Vanguard S&p 500 Etp (VOO)
Alphabet Inc-c Common Stock (GOOG)
Spdr S&p 500 Etf Equity Option Put Option (SPY)
Danaher Corp Common Stock (DHR)
Meta Platforms-a Common Stock (META)
Netflix Common Stock (NFLX)
Costco Wholesale Common Stock (COST)
Procter & Gamble Common Stock (PG)
Adv Micro Device Common Stock (AMD)

View all positions for Marshall Wace

Top funds holding An2 Therapeutics

RA Capital Management
Citadel Advisors
Frazier Life Sciences Management
BVF
Henderson Group
Avidity Partners Management
Octagon Capital Advisors
Vanguard Group
Adage Capital Partners GP
BlackRock
Susquehanna International
Geode Capital Management
Acadian Asset Management
Walleye Trading Advisors
Alyeska Investment Group

View all funds holding An2 Therapeutics